Thermo Fisher Scientific Inc.
TMONYSECIK 97745TechnologyFiscal year ends Dec 31
Reports and events: 357 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000097745-26-000181 |
| 2026-10-3010:52 ET | 10-Q | Quarterly reportPeriod 2026-09-26 | 0000097745-26-000179 |
| 2026-10-2106:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-26-000173 |
| 2026-07-3110:51 ET | 10-Q | Quarterly reportPeriod 2026-06-27 | 0000097745-26-000144 |
| 2026-07-2306:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-26-000138 |
| 2026-05-2607:31 ET | 8-K | 5.07 Shareholder vote results | 0000097745-26-000117 |
| 2026-05-0111:00 ET | 10-Q | Quarterly reportPeriod 2026-03-28 | 0000097745-26-000092 |
| 2026-04-2306:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-26-000086 |
| 2026-04-0708:14 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001193125-26-144585 |
| 2026-03-2408:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000097745-26-000066 |
| 2026-02-2612:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000097745-26-000018 |
| 2026-02-1216:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-005014 |
| 2026-01-2906:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-26-000012 |
| 2026-01-1206:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-000871 |
| 2025-12-0116:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-043790 |
| 2025-10-3109:36 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0000097745-25-000159 |
| 2025-10-2906:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000097745-25-000156 |
| 2025-10-2206:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-25-000150 |
| 2025-10-0716:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-037501 |
| 2025-09-0208:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000097745-25-000111 |
| 2025-08-0110:41 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0000097745-25-000101 |
| 2025-07-2316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000097745-25-000095 |
| 2025-07-2306:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-25-000093 |
| 2025-05-2816:15 ET | 8-K | 5.07 Shareholder vote results | 0000097745-25-000069 |
| 2025-05-2216:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000097745-25-000066 |
| 2025-05-0210:04 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0000097745-25-000041 |
| 2025-04-2306:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-25-000034 |
| 2025-04-0807:30 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001193125-25-075101 |
| 2025-02-2516:17 ET | 8-K | 8.01 Other events | 0000097745-25-000016 |
| 2025-02-2013:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000097745-25-000010 |
| 2025-02-1916:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000097745-25-000007 |
| 2025-01-3006:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-25-000003 |
| 2024-11-0111:36 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0000097745-24-000046 |
| 2024-10-2306:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-24-000043 |
| 2024-08-0210:00 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0000097745-24-000040 |
| 2024-07-2406:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-24-000036 |
| 2024-07-1016:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950157-24-000978 |
| 2024-05-2416:18 ET | 8-K | 5.07 Shareholder vote results | 0000097745-24-000026 |
| 2024-05-0311:04 ET | 10-Q | Quarterly reportPeriod 2024-03-30 | 0000097745-24-000023 |
| 2024-04-2406:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-24-000019 |
| 2024-04-0907:16 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001193125-24-090173 |
| 2024-03-1416:17 ET | SC 13D/A | Ownership report, active investor, amended | 0000950157-24-000414 |
| 2024-02-2213:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000097745-24-000007 |
| 2024-01-3106:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-24-000003 |
| 2023-12-0516:21 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-056365 |
| 2023-11-0716:15 ET | 8-K | 5.04 Item not in the standard list; 9.01 Financial statements and exhibits | 0000097745-23-000072 |
| 2023-11-0313:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000097745-23-000069 |
| 2023-10-2506:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000097745-23-000065 |
| 2023-10-1709:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950157-23-001058 |
| 2023-09-2116:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000097745-23-000062 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:55 ET. Listed shows no prices and gives no investment advice.